• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

drugdelivery

Nemera’s Innovation Center reaches 100 employees

January 10, 2019 By drugdelivery

Nemera Innovation Center - 100 employees

(Press Release) – Nemera‘s celebrated an important milestone: its Innovation center has just hired its 100th employee. The Innovation Center, a multi-discipline drug delivery device development expertise center, was created in 2008. Early on, it included a few engineers, who worked on product development. Over the last 10 years, it has grown consistently to reach […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Nemera

VIVA 2018 Roundup: Surmodics reports positive one-year data for SurVeil drug-coated balloon

November 8, 2018 By drugdelivery

VIVA 2018

By Sarah Faulkner & Fink Densford Surmodics (NSDQ:SRDX) touted data this week from an early feasibility study of the company’s SurVeil drug-coated balloon in patients with symptomatic peripheral artery disease due to de novo lesions of the femoral and popliteal arteries. All of the study’s 13 subjects met the acute success measures of safety at […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Pharmaceuticals, Vascular, Wall Street Beat Tagged With: SurModics Inc.

Materials for needle-free injection technology: What you need to know

October 25, 2018 By drugdelivery

Specially formulated polycarbonates help advance drug delivery innovation that improves patient experience and promotes better medication compliance. Douglas Hamilton, Covestro Diabetes is on the rise. The International Diabetes Federation (IDF) estimates there are roughly 415 million people affected by this chronic condition. By 2045, this is expected to rise to 629 million. For many, living with diabetes requires […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: covestro

Lubrizol LifeSciences & Particle Sciences to host micro- & nano-particulate drug product development seminar

June 21, 2018 By drugdelivery

Lubrizol logo

[PRESS RELEASE] – The Lubrizol Corporation announces its LifeSciences Pharmaceutical business will organize the first annual “Complex Drug Delivery Seminar: Micro- and Nano- Particulate Drug Product Development and Manufacturing” in Amsterdam on Thursday, September 27, 2018. Lubrizol LifeSciences through its pharmaceutical CDMO, Particle Sciences, and Co-Sponsor, Corbion, a world leader in bioresorbable polymers, would like to invite […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: lubrizol

Clinical Study Requirements: Drugs vs. Devices

December 12, 2016 By drugdelivery

Whether developing a new drug or medical device, designing and running clinical trials can be daunting. How drugs and devices are developed differ dramatically. Study design and regulatory pathways differ; requirements for study sites, end users, training, endpoints and follow up are all variables. This paper examines the key differences and how those impact clinical […]

Filed Under: Featured Tagged With: Novella Clinical

From Zero to Six Million – Using a Component Management Process to Scale Up Manufacturing of Drug Delivery Devices

November 11, 2016 By drugdelivery

Drug delivery devices constitute one of the most rapidly growing segments of the medical device manufacturing market. Makers focus substantial R&D efforts on designing delivery mechanisms for new and existing drug formulations. However, even good initial designs can’t guarantee that all the parts for these devices can be manufactured correctly and assembled consistently, with few […]

Filed Under: Featured

PsiOxus Therapeutics shuffles the deck

September 19, 2016 By drugdelivery

PsiOxus Therapeutics shuffles the deck PsiOxus said it named Dr. Charles Morris as its chief development officer and Karen LaRochelle as its chief business officer. Morris comes from ImmunoGen, where he was chief development officer, bringing its lead candidate to Phase III development. Most recently, LaRochelle was the executive director of global business development at […]

Filed Under: Business/Financial News, Drug-Device Combinations Tagged With: Alphatec Holdings Inc., Integer Holdings, Personnel Moves, PsiOxus Therapeutics

Mylan CEO to testify before House panel over EpiPen pricing

September 14, 2016 By drugdelivery

Mylan

(Reuters) –Mylan (NSDQ:MYL) Chief Executive Officer Heather Bresch will appear at a Sept. 21 congressional hearing over price increases for its EpiPen emergency allergy treatment, the U.S. House of Representatives Oversight Committee said in a statement on Wednesday. Mylan has been widely criticized, including by U.S. Democratic presidential candidate Hillary Clinton, for sharply raising the price […]

Filed Under: Drug-Device Combinations, Legal News, Wall Street Beat Tagged With: Mylan

Novocure touts data from Optune-paclitaxel combination study

September 2, 2016 By drugdelivery

By Sarah Faulkner NovoCure (NSDQ:NVCR) announced yesterday that its ‘tumor treating fields, combined with the drug paclitaxel, are effective against ovarian cancer, the 5th most-common cause of cancer death in women in the US. The St. Helier, N.J.-based company won FDA approval in July for the Optune device to treat a type of brain cancer called glioblastoma. TTFields […]

Filed Under: Clinical Trials, Drug-Device Combinations, Oncology Tagged With: NovoCure

PharmaJet inks pact with World Health Organization for polio vaccine

August 31, 2016 By drugdelivery

By Sarah Faulkner PharmaJet said yesterday that it inked a multi-year partnership as part of the World Health Organization’s effort to eradicate polio, using the Colorado-based company’s needle-free technology. Their Tropis device administers medication through the skin, without the use of needles. Although polio has been eradicated from the Americas, Europe, South East Asia and the Western […]

Filed Under: Drug-Device Combinations Tagged With: PharmaJet, Polio, World Health Organization

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 10
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS